van Steenbrugge GJ - Search Results

1

The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.

van Steenbrugge GJ, Groen M, van Dongen JW, Bolt J, van der Korput H, Trapman J, Hasenson M, Horoszewicz J. van Steenbrugge GJ, et al. Among authors: van dongen jw, van der korput h. Urol Res. 1989;17(2):71-7. doi: 10.1007/BF00262024. Urol Res. 1989. PMID: 2660395 Review.

2

The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.

van Steenbrugge GJ, van Uffelen CJ, Bolt J, Schröder FH. van Steenbrugge GJ, et al. Among authors: van uffelen cj. J Steroid Biochem Mol Biol. 1991;40(1-3):207-14. doi: 10.1016/0960-0760(91)90184-7. J Steroid Biochem Mol Biol. 1991. PMID: 1958522 Review.

3

The cytocidal effect of high energy shock waves on human prostatic tumour cell lines.

van Dongen JW, van Steenbrugge GJ, Romijn JC, Schröder FH. van Dongen JW, et al. Among authors: van steenbrugge gj. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1173-9. doi: 10.1016/0277-5379(89)90411-2. Eur J Cancer Clin Oncol. 1989. PMID: 2767106

4

Regulation of androgen receptor expression in the human heterotransplantable prostate carcinoma PC-82.

Ruizeveld de Winter JA, van Weerden WM, Faber PW, van Steenbrugge GJ, Trapman J, Brinkmann AO, van der Kwast TH. Ruizeveld de Winter JA, et al. Among authors: van weerden wm, van steenbrugge gj, van der kwast th. Endocrinology. 1992 Dec;131(6):3045-50. doi: 10.1210/endo.131.6.1446639. Endocrinology. 1992. PMID: 1446639

5

Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.

Zhao X, van Steenbrugge GJ, Schröder FH. Zhao X, et al. Among authors: van steenbrugge gj. Urol Res. 1992;20(3):193-7. doi: 10.1007/BF00299716. Urol Res. 1992. PMID: 1615580 Free article.

6

Transplantable human prostatic carcinoma (PC-82) in athymic nude mice. III. Effects of estrogens on the growth of the tumor tissue.

van Steenbrugge GJ, Groen M, van Kreuningen A, de Jong FH, Gallee MP, Schröder FH. van Steenbrugge GJ, et al. Among authors: van kreuningen a. Prostate. 1988;12(2):157-71. doi: 10.1002/pros.2990120206. Prostate. 1988. PMID: 3368404

7

Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.

Vlietstra RJ, van Alewijk DC, Hermans KG, van Steenbrugge GJ, Trapman J. Vlietstra RJ, et al. Among authors: van alewijk dc, van steenbrugge gj. Cancer Res. 1998 Jul 1;58(13):2720-3. Cancer Res. 1998. PMID: 9661880

8

Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation.

Verkaik NS, Trapman J, Romijn JC, Van der Kwast TH, Van Steenbrugge GJ. Verkaik NS, et al. Among authors: van steenbrugge gj, van der kwast th. Int J Cancer. 1999 Jan 29;80(3):439-43. doi: 10.1002/(sici)1097-0215(19990129)80:3<439::aid-ijc17>3.0.co;2-v. Int J Cancer. 1999. PMID: 9935187

9

Expression of cellular oncogenes in human prostatic carcinoma cell lines.

Rijnders AW, van der Korput JA, van Steenbrugge GJ, Romijn JC, Trapman J. Rijnders AW, et al. Among authors: van steenbrugge gj, van der korput ja. Biochem Biophys Res Commun. 1985 Oct 30;132(2):548-54. doi: 10.1016/0006-291x(85)91168-4. Biochem Biophys Res Commun. 1985. PMID: 3904752

10

Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.

Dohle GR, Beekhuis JA, van Steenbrugge GJ, Schröder FH, Tanke HJ. Dohle GR, et al. Among authors: van steenbrugge gj. Urol Res. 1996;24(5):251-5. doi: 10.1007/BF00304773. Urol Res. 1996. PMID: 8931288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters